These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 33495310)

  • 1. Imaging Tumor-Infiltrating Lymphocytes in Brain Tumors with [
    Nagle VL; Henry KE; Hertz CAJ; Graham MS; Campos C; Parada LF; Pandit-Taskar N; Schietinger A; Mellinghoff IK; Lewis JS
    Clin Cancer Res; 2021 Apr; 27(7):1958-1966. PubMed ID: 33495310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring CD8a
    Kristensen LK; Christensen C; Alfsen MZ; Cold S; Nielsen CH; Kjaer A
    Mol Imaging Biol; 2020 Aug; 22(4):1021-1030. PubMed ID: 32086762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noninvasive Imaging of CD4+ T Cells in Humanized Mice.
    Nagle VL; Hertz CAJ; Henry KE; Graham MS; Campos C; Pillarsetty N; Schietinger A; Mellinghoff IK; Lewis JS
    Mol Cancer Ther; 2022 Apr; 21(4):658-666. PubMed ID: 35131877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urokinase-Type Plasminogen Activator Receptor as a Potential PET Biomarker in Glioblastoma.
    Persson M; Nedergaard MK; Brandt-Larsen M; Skovgaard D; Jørgensen JT; Michaelsen SR; Madsen J; Lassen U; Poulsen HS; Kjaer A
    J Nucl Med; 2016 Feb; 57(2):272-8. PubMed ID: 26429955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD8
    Seo JW; Tavaré R; Mahakian LM; Silvestrini MT; Tam S; Ingham ES; Salazar FB; Borowsky AD; Wu AM; Ferrara KW
    Clin Cancer Res; 2018 Oct; 24(20):4976-4987. PubMed ID: 29967252
    [No Abstract]   [Full Text] [Related]  

  • 6. CD4
    Kristensen LK; Fröhlich C; Christensen C; Melander MC; Poulsen TT; Galler GR; Lantto J; Horak ID; Kragh M; Nielsen CH; Kjaer A
    Theranostics; 2019; 9(26):8221-8238. PubMed ID: 31754392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating the immunologically "cold" tumor microenvironment after treatment with immune checkpoint inhibitors utilizing PET imaging of CD4 + and CD8 + T cells in breast cancer mouse models.
    Lu Y; Houson HA; Gallegos CA; Mascioni A; Jia F; Aivazian A; Song PN; Lynch SE; Napier TS; Mansur A; Larimer BM; Lapi SE; Hanker AB; Sorace AG
    Breast Cancer Res; 2024 Jun; 26(1):104. PubMed ID: 38918836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ImmunoPET imaging of human CD8
    Zhao H; Wang C; Yang Y; Sun Y; Wei W; Wang C; Wan L; Zhu C; Li L; Huang G; Liu J
    J Nanobiotechnology; 2021 Feb; 19(1):42. PubMed ID: 33563286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting VPAC1 Receptors for Imaging Glioblastoma.
    Tripathi SK; Kean R; Bongiorno E; Hooper DC; Jin YY; Wickstrom E; McCue PA; Thakur ML
    Mol Imaging Biol; 2020 Apr; 22(2):293-302. PubMed ID: 31292914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PET imaging of insulin-like growth factor type 1 receptor expression with a 64Cu-labeled Affibody molecule.
    Su X; Cheng K; Liu Y; Hu X; Meng S; Cheng Z
    Amino Acids; 2015 Jul; 47(7):1409-19. PubMed ID: 25854877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noninvasive Detection of HER2 Expression in Gastric Cancer by
    Guo X; Zhu H; Zhou N; Chen Z; Liu T; Liu F; Xu X; Jin H; Shen L; Gao J; Yang Z
    Mol Pharm; 2018 Nov; 15(11):5174-5182. PubMed ID: 30251865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical ImmunoPET Imaging of Glioblastoma-Infiltrating Myeloid Cells Using Zirconium-89 Labeled Anti-CD11b Antibody.
    Nigam S; McCarl L; Kumar R; Edinger RS; Kurland BF; Anderson CJ; Panigrahy A; Kohanbash G; Edwards WB
    Mol Imaging Biol; 2020 Jun; 22(3):685-694. PubMed ID: 31529407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical Evaluation of [
    Peng T; Wang X; Li Z; Bi L; Gao J; Yang M; Wang Y; Yao X; Shan H; Jin H
    Mol Pharm; 2021 Sep; 18(9):3638-3648. PubMed ID: 34424706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PET Imaging of Tissue Factor in Pancreatic Cancer Using 64Cu-Labeled Active Site-Inhibited Factor VII.
    Nielsen CH; Jeppesen TE; Kristensen LK; Jensen MM; El Ali HH; Madsen J; Wiinberg B; Petersen LC; Kjaer A
    J Nucl Med; 2016 Jul; 57(7):1112-9. PubMed ID: 27013699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting CAIX with [
    Yang X; Zhu H; Yang X; Li N; Huang H; Liu T; Guo X; Xu X; Xia L; Deng C; Tian X; Yang Z
    Mol Pharm; 2019 Apr; 16(4):1532-1540. PubMed ID: 30803240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
    Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS
    J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The PET-Tracer
    Griessinger CM; Olafsen T; Mascioni A; Jiang ZK; Zamilpa C; Jia F; Torgov M; Romero JM; Marchioni F; Satpayev D; Lee C; Zhang G; Nayak TK; Pincha M; Amann M; Mohan PLB; Richard M; Nicolini VG; Sam J; Claus C; Ferrara C; Brünker P; Bacac M; Umana P; Rüttinger D; Wilson IA; Gudas J; Klein C; Tessier JJL
    Cancer Res; 2020 Jul; 80(13):2903-2913. PubMed ID: 32409308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD8-Targeted PET Imaging of Tumor-Infiltrating T Cells in Patients with Cancer: A Phase I First-in-Humans Study of
    Farwell MD; Gamache RF; Babazada H; Hellmann MD; Harding JJ; Korn R; Mascioni A; Le W; Wilson I; Gordon MS; Wu AM; Ulaner GA; Wolchok JD; Postow MA; Pandit-Taskar N
    J Nucl Med; 2022 May; 63(5):720-726. PubMed ID: 34413145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immuno-PET Imaging of CD69 Visualizes T-Cell Activation and Predicts Survival Following Immunotherapy in Murine Glioblastoma.
    Nisnboym M; Vincze SR; Xiong Z; Sneiderman CT; Raphael RA; Li B; Jaswal AP; Sever RE; Day KE; LaToche JD; Foley LM; Karimi H; Hitchens TK; Agnihotri S; Hu B; Rajasundaram D; Anderson CJ; Blumenthal DT; Pearce TM; Uttam S; Nedrow JR; Panigrahy A; Pollack IF; Lieberman FS; Drappatz J; Raphael I; Edwards WB; Kohanbash G
    Cancer Res Commun; 2023 Jul; 3(7):1173-1188. PubMed ID: 37426447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-terminal modifications improve the receptor affinity and pharmacokinetics of radiolabeled peptidic gastrin-releasing peptide receptor antagonists: examples of 68Ga- and 64Cu-labeled peptides for PET imaging.
    Gourni E; Mansi R; Jamous M; Waser B; Smerling C; Burian A; Buchegger F; Reubi JC; Maecke HR
    J Nucl Med; 2014 Oct; 55(10):1719-25. PubMed ID: 25146125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.